Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients M Pibernik-Okanovic, M Prasek, T Poljicanin-Filipovic, I Pavlic-Renar, ... Patient education and counseling 52 (2), 193-199, 2004 | 205 | 2004 |
Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in type 1 diabetes K Kølendorf, GP Ross, I Pavlic‐Renar, G Perriello, A Philotheou, J Jendle, ... Diabetic medicine 23 (7), 729-735, 2006 | 131 | 2006 |
Treatment approach to type 2 diabetes: Past, present and future K Blaslov, FS Naranđa, I Kruljac, IP Renar World journal of diabetes 9 (12), 209, 2018 | 123 | 2018 |
Prevalence of diabetes mellitus in Croatia Ž Metelko, I Pavlić-Renar, T Poljičanin, L Szirovitza, S Turek Diabetes research and clinical practice 81 (2), 263-267, 2008 | 100 | 2008 |
A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes I Gornik, A Vujaklija-Brajković, IP Renar, V Gašparović Critical care 14, 1-8, 2010 | 75 | 2010 |
Pulmonary infections in diabetes mellitus S Ljubic, A Balachandran, I Pavlic-Renar, A Barada, Z Metelko Diabetol Croat 33 (4), 115-124, 2004 | 75 | 2004 |
Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria J Djelmis, M Pavić, VM Kotori, IP Renar, M Ivanisevic, S Oreskovic International Journal of Gynecology & Obstetrics 135 (3), 250-254, 2016 | 64 | 2016 |
Hrvatske smjernice za liječenje šećerne bolesti tipa 2 S Kokić, M Prašek, I Pavlić Renar, D Rahelić, E Pavić, M Jandrić Balen, ... Medix 17 (2), 8-34, 2011 | 61 | 2011 |
Hrvatske smjernice za farmakološko liječenje šećerne bolesti tipa 2 D Rahelić, V Altabas, M Bakula, S Balić, I Balint, B Bergman Marković, ... Liječnički vjesnik 138 (1-2), 1-21, 2016 | 58 | 2016 |
Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians M Korolija, IP Renar, M Hadžija, EP Medvidović, P Pavković, M Jokić, ... Diabetes research and clinical practice 86 (3), e54-e57, 2009 | 50 | 2009 |
Obesity–risk factor for microvascular and neuropathic complications in diabetes M Tomić, T Poljičanin-Filipović, I Pavlić-Renar Hrvatski dijabetološki kongres (2; 2001), 32-32, 2001 | 47 | 2001 |
Dermatologic lesions in diabetes mellitus C Sreedevi, N Car, I Pavlic-Renar Diabetologia croatica 31 (3), 147-159, 2002 | 40 | 2002 |
Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes B Ročić, M Vučić, J Knežević-Ćuća, A Radica, I Pavlić-Renar, V Profozić, ... Experimental and clinical endocrinology & diabetes 105 (04), 213-217, 1997 | 39 | 1997 |
Incidence of IDDM during 1988–1992 in Zagreb, Croatia G Roglić, I Pavlić-Renar, S Šestan-Crnek, M Prašek, ... Diabetologia 38 (5), 550-554, 1995 | 35 | 1995 |
Šećerna bolest u odraslih M Vrca Botica, I Pavlić Renar | 25 | 2012 |
Dijagnostika i liječenje šećerne bolesti tipa 1 I Pavlić Renar Medix 80 (81), 100-106, 2009 | 21 | 2009 |
Interaction of depressive symptoms and diabetes‐related distress with glycaemic control in Type 2 diabetic patients M Pibernik‐Okanovic, M Grgurevic, D Begic, S Szabo, Z Metelko Diabetic Medicine 25 (10), 1252-1254, 2008 | 21 | 2008 |
Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes K Kolendorf, I Pavlić-Renar, F Santeusanio, A Philotheou, MA Gall, ... Nepoznat skup, A130-A131, 2004 | 20 | 2004 |
Structure of visits persons with diabetes in Croatian family practice–analysis of reasons for encounter and treatment procedures using the ICPC-2 M Vrca Botica, I Zelić, I Pavlić Renar, B Bergman Marković, ... Collegium antropologicum 30 (3), 495-499, 2006 | 17 | 2006 |
Cytogenetic effects of met-enkephalin (peptid-M) on human lymphocytes N Štambuk, N Kopjar, K Šentija, V Garaj-Vrhovac, D Vikić-Topić, ... Croatica chemica acta 71 (3), 591-605, 1998 | 17 | 1998 |